Quantinuum (pre-IPO) 

QNT Price

🌱 5d

What is Quantinuum (QNT) pre-IPO stock?

Quantinuum (QNT) is a pre-IPO market that gives traders synthetic exposure to the market-implied price per share of Quantinuum Inc. Class A common stock — not a crypto token and not an asset issued by Quantinuum. Quantinuum is a quantum computing company formed in 2021 through the merger of Honeywell Quantum Solutions and Cambridge Quantum, majority-owned by Honeywell. DropsTab lists Quantinuum (QNT) under its TradFi category, where the price tracks Quantinuum's expected listing value ahead of its NASDAQ debut.

Is Quantinuum (QNT) the same as Quant Network (QNT)?

No — Quantinuum (QNT) and Quant Network (QNT) share only a ticker string. Quantinuum (QNT) on DropsTab is a pre-IPO derivative tracking the share price of Quantinuum Inc., a quantum computing company. Quant Network (QNT) is a separate ERC-20 utility token that powers the Overledger interoperability platform and carries a fixed supply of 14.6 million. The two are unrelated assets — Quantinuum has never issued a crypto token, so Quant Network token metrics do not apply to Quantinuum (QNT).

What does the Quantinuum (QNT) pre-IPO contract represent?

The Quantinuum (QNT) contract represents the market-implied price of one share of Quantinuum Inc. Class A common stock. Quantinuum (QNT) contracts are synthetic perpetual futures — no actual shares change hands, and holding a contract conveys no shareholder rights, dividends, or equity ownership. The Quantinuum (QNT) price stays anchored to a reference valuation through oracle feeds and funding payments between long and short positions. Quantinuum (QNT) therefore lets traders express a view on Quantinuum's valuation without buying private stock.

How is Quantinuum (QNT) traded — spot or perpetual futures?

Quantinuum (QNT) trades exclusively as perpetual futures, not spot — there is no underlying token or share to custody. Quantinuum (QNT) exposure runs across both centralized exchanges and the Hyperliquid DEX, with centralized venues carrying the large majority of volume and Hyperliquid serving as the main on-chain venue. Per DropsTab, the Quantinuum (QNT) pre-IPO market launched on 29 May 2026. Quantinuum (QNT) positions are leveraged, so funding-rate costs accrue on held positions and liquidation risk applies — the contract suits short-term speculation, not buy-and-hold ownership.

Is Quantinuum publicly traded yet?

Quantinuum is not yet publicly traded as of early June 2026 — Quantinuum (QNT) is a pre-IPO instrument, not the listed stock. Quantinuum filed its public S-1 on 8 May 2026. Per its 1 June 2026 amended filing, Quantinuum plans to sell 26.5 million shares at $53–55 to raise up to roughly $1.46 billion. The upsized offering targets a valuation of up to $14.3 billion, above the $12.7 billion implied by the initial filing. Quantinuum is set to begin trading on NASDAQ on 4 June 2026 under the ticker QNT.

What happens to the Quantinuum (QNT) contract after the IPO?

Once Quantinuum begins trading on NASDAQ on 4 June 2026, the Quantinuum (QNT) contract's reference price switches from an implied pre-IPO valuation to the live stock price. Quantinuum (QNT) then continues as a standard equity perpetual, so open positions can remain open without forced closure. This conversion shifts Quantinuum (QNT) from pricing the market's IPO expectation to tracking Quantinuum's actual public-market performance. If the IPO were delayed or cancelled, each exchange settles the Quantinuum (QNT) contract through its own disclosed process.

Who owns Quantinuum?

Honeywell is Quantinuum's majority owner and retains roughly 49.1% of voting power after the IPO, while Cambridge Quantum Holdings holds about 32.5% — together the founding shareholders keep around 82% of equity. Quantinuum's founder, Ilyas Khan, is the largest individual shareholder, with a stake worth over $2 billion at the offering price, and now serves as Chief Product Officer. Quantinuum is led by CEO Rajeeb Hazra, a former Intel executive, with Honeywell's Vimal Kapur as board chairman. This concentrated ownership keeps strategic control with Honeywell after listing.

What does Quantinuum do as a quantum computing company?

Quantinuum builds full-stack quantum computing technology, specializing in trapped-ion quantum computers such as its H-Series and Helios systems, plus software including Quantum Origin, InQuanto, and Nexus. Quantinuum targets applications in cryptography, chemistry, optimization, and machine learning. Quantinuum reported revenue of $30.9 million for 2025 against a net loss of $192.6 million, so Quantinuum remains pre-profit and heavily reinvesting in R&D. Quantinuum's closest trapped-ion rival, IonQ, posted quarterly revenue exceeding Quantinuum's combined revenue for the prior two years — a sign Quantinuum trails on commercial maturity.